CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-19 | Hunt Anthony Chief Executive Officer | Sale | −2,819 | $174.41 | $492K | 190,875 |
| 2021-05-19 | Hunt Anthony Chief Executive Officer | Sale | −380 | $175.15 | $67K | 190,495 |
| 2021-05-14 | Gebski Christine | Sale | −445 | $172.25 | $77K | 36,695 |
| 2021-05-14 | KURIYEL RALF Senior VP, R&D | Sale | −710 | $172.29 | $122K | 24,555 |
| 2021-05-14 | Snodgres Jon Chief Financial Officer | Sale | −470 | $172.60 | $81K | 31,893 |
| 2021-05-13 | EGLINTON MANNER CARRIE Director | Grant or award | +457 | 457 | ||
| 2021-05-13 | EGLINTON MANNER CARRIE Director | Grant or award · Stock Option (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-13 | MUIR GLENN P Director | Grant or award | +457 | 6,362 | ||
| 2021-05-13 | MUIR GLENN P Director | Grant or award · Stock Option (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-13 | BARTHELEMY NICOLAS Director | Grant or award | +457 | 1,907 | ||
| 2021-05-13 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-13 | RYAN THOMAS F JR Director | Grant or award | +457 | 1,751 | ||
| 2021-05-13 | RYAN THOMAS F JR Director | Grant or award · Stock Option (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-13 | Mhatre Rohin Director | Grant or award | +457 | 457 | ||
| 2021-05-13 | Mhatre Rohin Director | Grant or award · Stock Option (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-13 | DAWES KAREN A Director | Grant or award | +604 | 116,053 | ||
| 2021-05-13 | DAWES KAREN A Director | Grant or award · Stock Option (Right to Buy) | +1,522 | 1,522 | ||
| 2021-05-11 | DAWES KAREN A Director | Exercise or conversion | +15,000 | $3.22 | $48K | 115,734 |
| 2021-05-11 | DAWES KAREN A Director | Sale | −285 | $176.85 | $50K | 115,449 |
| 2021-05-11 | DAWES KAREN A Director | Exercise or conversion · Stock Option (Right to Buy) | −15,000 | 0 |
Page 28 of 42 · 832 trades